Skip to main content
AXNX logo

Axonex AI Group Limited (AXNX) Stock Price & Analysis

Axonex AI Group Limited (AXNX) — MoonshotScore 17/100 (Weak band), calculated Nov 22, 2026. Price $0.8301 (-8.28%), as of the Nov 20, 2026 trading session; market cap $5.04M.

Educational signal · not a buy or sell recommendation · How to read this

$0.8301 −$0.0749 (-8.28%) Market Cap $5.04M

Axonex AI Group Limited · AXNX · NASDAQ

Axonics, Inc. focuses on developing and commercializing sacral neuromodulation (SNM) systems for treating bladder and bowel dysfunction. Their rechargeable SNM system and Bulkamid product offer solutions for overactive bladder, urinary incontinence, and fecal incontinence.

Price as of Nov 20, 2026

Key Statistics

17 of 100

MoonshotScore v2 · Axonex AI Group (AXNX)

Weak
Business Quality Poor (6)
Financial Safety Fragile (5)
Valuation Rich (34)
Growth Durability Shrinking (6)
Momentum Falling (8)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a fragile balance sheet and stalling growth, and it’s expensive on top — broad distress, a capital-preservation call, not a value entry. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Poor; Financial Safety: Fragile; Valuation: Rich; Growth Durability: Shrinking; Momentum: Falling.

  • quarterly revenue $167,051 (Q4 FY2026, quarter ended Mar 31, 2026)
  • Altman Z -2.31 · Piotroski F 2

Holding back: weak fundamentals, balance-sheet strain, a rich price, soft growth, weak price trend

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for AXNX (23 recorded, newest six shown)
RecordedScoreBand
17Weak
17Weak
17Weak
17Weak
17Weak
17Weak

The score was 17 in the stored Nov 21, 2026 snapshot and remains 17 in the current publication computed Nov 22, 2026 (0); the largest pillar moves were Business Quality +1 and Momentum +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.8301
Change on the day-8.28%
52-week range$0.68 – $18.35
Market capitalisation$5.04M
Shares traded on the day26.9K

Price & events

Other perspectives

Council score for Axonex AI Group (AXNX): perspectives

Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.

5-Factor Breakdown

Business Quality Negative
Financial Safety Negative
Valuation Weak
Growth Durability Negative
Momentum Negative

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Unfavorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Nov 22, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Neutral
ROE Negative
Gross Margin Weak

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

Two of these lenses read this company more favourably than the MoonshotScore does: Dalio-style lens and Englander-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 22, 2026, except a card that shows its own read date.

1 · What is it?

What is Axonex AI Group (AXNX), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Axonex AI Group Limited (AXNX) is listed on NASDAQ. It employs 36 people and is led by Hoi Lung Chan. In Q4 FY2026 it reported revenue of $167,051 and net income of -$222,175. The market values it at $5.04M.

2 · Latest results

What do the latest results show for Axonex AI Group (AXNX)?

Short answer · as of

The most recent reported quarter, Q4 FY2026, carried revenue of $167,051.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q4 FY2026$167,051-$222,175-$0.22 (diluted)
Q2 FY2026$126,511-$1M-$1.10 (diluted)
Q4 FY2025$963,447-$796,514-$0.91 (diluted)
Q3 FY2025$963,447-$796,514-$0.91 (diluted)

Data check: No usable statement is on file for the period between Q4 FY2025 and Q2 FY2026; that quarter is left out rather than estimated. No usable statement is on file for the period between Q2 FY2026 and Q4 FY2026; that quarter is left out rather than estimated. Nothing in this table has been filled in or adjusted.

3 · Financial strengths and risks

What are the financial strengths and risks for Axonex AI Group (AXNX)?

Short answer · as of

What is holding it back is weak fundamentals, balance-sheet strain, a rich price, soft growth, weak price trend. The distress and quality screens read Altman Z -2.31 · Piotroski F 2. Trailing ratios: ROA -98.3% · current ratio 1.89.

Data-derived red flags

  • Listing risk — at $0.8301 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Financial-distress signal — its Altman Z-Score of -2.31 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
5 · Peer comparison

How does Axonex AI Group compare with its peers?

Short answer

Axonex AI Group's score ranks 11th of 12 in the bounded comparison shown, against 11 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Team, Inc. (TISI) Same industry, near in market value$25.73 Nov 20, 2026$119M36 5-pillar Nov 22, 2026
Primech Holdings Ltd. (PMEC) Same industry, near in market value$0.35 Nov 20, 2026$13.5M35 5-pillar Nov 22, 2026
DLH Holdings Corp. (DLHC) Same industry, near in market value$2.73 Nov 20, 2026$39.6M33 5-pillar Nov 22, 2026
PPHC (PPHC) Same industry, near in market value$9.25 Nov 20, 2026$283M29 5-pillar Nov 22, 2026
TryHard Holdings Limited (THH) Same industry, near in market value$1.02 Nov 20, 2026$5.10M28 5-pillar Nov 22, 2026
Rich Sparkle Holdings Limited (ANPA) Same industry, near in market value$1.13 Nov 20, 2026$17.1M25 5-pillar Nov 22, 2026
Lichen International Limited (LICN) Same industry, near in market value$1.29 Nov 20, 2026—25 5-pillar Nov 22, 2026
Civeo Corporation (CVEO) Same industry, near in market value$32.22 Nov 20, 2026$333M20 5-pillar Nov 22, 2026
System1, Inc. (SST) Same industry, near in market value$0.67 Nov 20, 2026$7.16M19 5-pillar Nov 22, 2026
Odyssey Marine Exploration, Inc. (OMEX) Same industry, near in market value$6.39 Nov 20, 2026$15.0M18 5-pillar Nov 22, 2026
Axonex AI Group (AXNX) — this page$0.8301$5.04M17
Spire Global, Inc. (SPIR) Same industry, near in market value$7.36 Nov 20, 2026$289M9 5-pillar Nov 22, 2026
Inari Medical, Inc. (NARI) Named competitor$79.97 Sep 22, 2026$4.68B— Model unavailable

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
1
Identified insiders
1
Purchases
1
Sales
0
Other transactions
0

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held AXNX in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported AXNX in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Axonex AI Group (AXNX)?

Read these with our analysis →

What Investors Ask About Axonex AI Group (AXNX)

These answers are editorial: 1 of these 9 answers is drawn from the AXNX research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for AXNX?

AXNX carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Axonics, Inc. focuses on developing and commercializing sacral neuromodulation (SNM) systems for treating bladder and bowel dysfunction.

Is AXNX a good stock to buy?

Stock Expert AI does not rate AXNX buy, sell or hold. Axonex AI Group Limited carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the AXNX stock price today?

The last price recorded for Axonex AI Group Limited (AXNX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What are the main risks for AXNX?

The main risks for Axonics, Inc. include competition from established medical device companies, regulatory hurdles and reimbursement challenges, and product liability claims.

What are the key factors to evaluate for AXNX?

Axonex AI Group Limited (AXNX) holds a MoonshotScore in the low range. These regions have a large population base and increasing healthcare spending. Not financial advice.

How frequently does AXNX data refresh on this page?

AXNX's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven AXNX's recent stock price performance?

Axonex AI Group Limited (AXNX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative rechargeable SNM system. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AXNX overvalued or undervalued right now?

Axonex AI Group Limited (AXNX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of AXNX?

Fractional-share availability for Axonex AI Group Limited (AXNX) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 16 figures on this page — 10 from Financial Modeling Prep (FMP), 4 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP)
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP — our AI writes the analysis, it never edits the figures.